XML 39 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
STATEMENTS OF CASH FLOWS (USD $)
12 Months Ended 128 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2012
Cash flow from operating activities:      
Net loss $ (7,422,155) $ (4,486,879) $ (19,291,111)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 1,079 3,175 10,644
Vested stock options and warrants 830,372 1,937,638 3,497,672
Equity instruments issued for management and consulting 3,919,828 507,126 5,789,768
Stock-based registration payments 0 0 355,124
Capital contributions resulting from waivers of debt 0 0 476,398
Amortization of debt discount 57,518 112,031 342,802
(Gain) loss on valuation of equity-linked instruments 3,116 151,118 (628,070)
Changes in assets and liabilities:      
Accounts receivable 10,583 (50,294) (39,711)
Inventories (47,604) (97,605) (145,209)
Prepaid expense and other assets 2,739 (22,022) (27,409)
Notes payable to shareholders 0 0 (14,957)
Accounts payable 421,104 71,714 1,718,839
Accrued expenses 1,039,255 92,367 1,717,689
Net cash used in operating activities: (1,184,165) (1,781,631) (6,237,531)
Cash flow from investing activities:      
Purchase of fixed assets 0 0 (12,258)
Purchase of intangibles 0 0 (142,495)
Net cash used in investing activities 0 0 (154,753)
Cash flow from financing activities:      
Proceeds from long-term and convertible debt 528,525 525,500 2,112,491
Repayment of convertible debt (150,000) 0 (250,000)
Principal payments on long-term debt 0 (16,267) (75,667)
Issuance of common stock 695,794 1,386,000 4,618,599
Net cash provided by (used in) financing activities 1,074,319 1,895,233 6,405,423
Net increase (decrease) in cash (109,846) 113,602 13,139
Cash at beginning of period 122,985 9,383 0
Cash at end of period 13,139 122,985 13,139
Non cash transactions:      
Conversion of debt to accrued liabilities 100,000 0 100,000
Common stock issued for accrued interest/bonus 106,310 24,500 218,170
Conversion of accounts payable to convertible debt 0 89,300 546,600
Common stock issued to satisfy debt 817,800 50,000 1,041,799
Stock/warrant issued to satisfy accounts payable/Liabilities $ 418,644 $ 20,000 $ 438,644